Open AccessGenetic and epigenetic studies offer new therapeutic options for the treatment of T-cell acute lymphoblastic leukemia
Author(s) -
Jan Cools
Publication year - 2012
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2012.064501
Subject(s) - epigenetics , genome , lymphoblastic leukemia , human genome , computational biology , sequence (biology) , biology , whole genome sequencing , genetics , bioinformatics , gene , medicine , leukemia
It took many years and an incredible amount of work to determine the draft of the human genome sequence, which was published in 2001.[1][1] Now, only ten years after the landmark paper describing the first human genome, whole genomes are being sequenced and analyzed at an increasing speed and depth
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom